SUMMARY Three groups of dogs were given ouabain (mean 60 ,ug/kg) until an accelerated ventricular escape (AVE) and repetitive ventricular response (RVR) followed cessation of pacing. In a group of six control dogs, the AVE and RVR were found to occur at stable escape intervals for periods of at least three hours. A second group of dogs received various antiarrhythmic agents in an attempt to suppress the AVE and RVR. Quinidine, diphenylhydantoin, lidocaine, procainamide, and propranolol, were successful in only 0 to 33% of trials. Potassium canrenoate, 12 mg/kg was unsuccessful in three dogs. Verapamil, by bolus, suppressed RVR in 41% and AVE in 21% of trials. KCI, infused until AVE and RVR were suppressed, was STUDIES BY Castellanos,' Lown,2' Wittenberg,4 and Zipes5 with their respective associates, demonstrated that following digitalis administration, ventricular escape beats could be elicited in the intact dog heart. Of interest was the fact that these escape beats exhibited overdrive acceleration, rather than overdrive suppression, and occurred at very consistent intervals. Observations from microelectrode studies performed by Ferrier et al.6 and Rosen et al.7 established a possible cellular basis for these escape beats, and Ferrier and Moe8 suggested that they may be dependent on transmembrane calcium fluxes involving the slow current.
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Because the intervals of these escape beats remain quite fixed to the preceding complex, when heart rate and number of cycles are held constant, the ventricular escape beats in the intact dog heart are quite amenable to testing the effects of various antiarrhythmic agents. In so doing, Whiting and Lown9 found that propranolol failed to suppress these ventricular escape beats. We considered that verapamil, a slowchannel blocker,'0 might be more effective than propranolol if the slow current plays an important role in the pathogenesis of these escape beats. The purpose of this study was to compare the efficacy of verapamil with other antiarrhythmic agents in suppressing these ventricular escapes. In addition, we evaluated the effects of a new antiarrhythmic agent, aprindine hydrochloride (AC-1802), a very potent local anesthetic agent"' 12 with electrophysiologic properties that resemble lidocaine in many ways,'3 but with possible slow-current blocking capabilities. '4 successful when the mean serum potassium rose from 3.8 mEq/L to 7.2 mEq/L. Aprindine, 2.86 mg/kg, suppressed AVE and RVR in 14 of 14 dogs. In the third group of dogs, verapamil was infused continuously and suppressed RVR and AVE at a mean cumulative dose of 2.93 mg/kg. Calcium chloride reversed aprindine and verapamilinduced suppression of RVR and AVE. This study demonstrates that RVR and AVE resist suppression by available antiarrhythmic agents in clinically-used doses. Only aprindine was 100% successful at doses used in man. The ionic pathogenesis of RVR and AVE is unknown, but some data suggest the slow current may play an important role.
Methods and Materials
Adult healthy mongrel dogs were anesthetized with sodium secobarbital, 30 mg/kg (repeated in doses of 2-5 mg/kg as needed to maintain anesthesia), and ventilated with a Harvard respirator. A heating blanket was used to maintain normal body temperature. Following cannulation of the external jugular vein and the common carotid artery, the heart was exposed via a midline sternotomy and was suspended in a pericardial sling. Arterial blood pressure was continuously monitored with a Statham strain gauge transducer (Model 23 BD) and 5% dextrose in normal saline was infused into the venous line (except during drug infusions) at a rate of approximately 200 ml/hr. The sinus node was crushed to achieve a slower spontaneous heart rate.
All recording and stimulating was performed using bipolar electrodes, having an interelectrode distance of 1-2 mm. These electrodes were made from stainless steel needles (0.3 mm diameter) which were bent in the shape of a J and insulated except for the curved portion and tip, which was hooked into the epicardium.
Recording electrodes were placed in the sinus node area, the right and left atrial appendages, and the midanterior right and left ventricles on either side of the septum. A standard lead II was also recorded. Tracings were displayed on a switched-beam oscilloscope (DR8 Electronics for Medicine) using filter settings between 40 Hz and 500 Hz and were recorded on photographic paper at speeds of 100 mm/sec. Measurements were made from the tracings on the photographic paper.
Stimulating basic cycle lengths of 300 and 350 msec. Following the last stimulus of the basic train, two events were studied. First, a premature stimulus was delivered 250-275 msec after the last basic pulse simultaneously to the right atrium and ventricle and pacing was discontinued for approximately 2 seconds to allow emergence of spontaneous activity, if any ( fig. lA,C) . Second, pacing was abruptly terminated following the last stimulus of the basic train without delivering the premature stimulus and pacing was resumed approximately 2 seconds later ( fig. 1B,D) .
Prior to ouabain administration, a supraventricular escape beat (atrial or junctional) occurred after the last paced beat, at cycle lengths usually exceeding 750-1000 msec ( fig.  1A,B) . These escape beats demonstrated overdrive suppression, i.e., a faster basic pacing rate was followed by a longer escape interval. Following ouabain administration, a ventricular escape beat resulted 385-600 msec after the last paced beat and exhibited overdrive acceleration, i.e., a faster basic pacing rate was followed by a shorter escape interval. For purposes of the present discussion, the ventricular escape beat which followed premature ventricular stimulation was called a repetitive ventricular response (RVR) (fig. IC)2' 3 while the ventricular escape beat which followed abrupt cessation of pacing was called an accelerated ventricular escape (AVE) ( fig. ID) . The term, escape, is used arbitrarily in this context and does not connote mechanism (i.e., automaticity or re-entry). Accelerated atrial escapes occurred, and also demonstrated overdrive acceleration,5 but generally at cycle lengths too long to conduct to the ventricle prior to the ventricular escape. When atrial escapes preceded ventricular escapes, conduction to the ventricle (with aberration) was ruled out by demonstrating the independent nature of the ventricular escape beats with a change in the programmed atrial stimulation.
Ouabain was administered intravenously, in an initial dose of 25 ug/kg with subsequent doses of 10-15 ,ug/kg at 30 minute intervals until stable ventricular escapes followed premature stimulation and cessation of pacing. The rhythms were continuously observed and recorded every five minutes on photographic paper. Escape intervals were measured to the electrogram of the earliest escaping ventricle.
In some studies, plunge wire recordings of His bundle activity confirmed that the escaping beats were of ventricular origin. Most often, the altered QRS contour and prolonged duration at cycle lengths which were known to permit normal ventricular conduction provided sufficient evidence of ventricular origin.5 Group 
Ouabain Controls
Three groups of dogs were studied. The first group of six dogs was studied to establish the stability and duration of the RVR and AVE. In these dogs, once a stable RVR and AVE were elicited with ouabain, no further drugs were given, and the duration of stable escape intervals was determined.
Group 2. Multiple Drug Comparison
The second group was studied to evaluate the efficacy of various antiarrhythmic agents in suppressing the RVR and AVE. This group consisted of 53 dogs given various antiarrhythmic agents following the onset of stable, ouabaininduced ventricular escape beats. Drugs were given as single injections intravenously over The third group of dogs (N = 16) was studied to determine the amount of verapamil that was required to suppress the RVR and AVE and to test whether calcium administration could overcome the suppressive effects of verapamil. In these dogs, verapamil Ag/kg/min) was infused, following initiation of stable RVR and AVE, until suppression occurred. Seven of these dogs were observed for 30 minutes to document the duration of verapamil-induced suppression; in nine dogs, calcium chloride (100 mg/min) was infused 15 minutes after discontinuing the verapamil to observe its effect on the lengthened ventricular escape intervals.
Definition of "Successful Suppression"
A "successful suppression" of ouabain-induced ventricular escapes (both RVR and AVE) by a particular drug was defined as a 50% or greater prolongation of the ventricular escape interval. The constancy of the ventricular escape intervals in the control dogs established that this degree of prolongation would be extremely significant (P < 0.0005). Measurements Results from this study demonstrate the remarkable resistance of the AVE and RVR to suppression by the common antiarrhythmic agents, even with doses clearly in the supraclinical or toxic range. A greater incidence of suppression might have been achieved in dogs which failed to suppress had we used cumulative doses of quinidine, diphenylhydantoin and lidocaine equal to the doses used in dogs which did suppress. Regardless, the doses for both groups were still quite excessive. Microelectrode studies in Purkinje fibers exposed to ouabain7 or acetylstrophanthidin' suggest that the cellular basis for these rhythms is the transient depolarizations (low amplitude potential),7 which could be suppressed in vitro by manganese' and verapamil. '8 However, our in vivo findings show verapamil was only slightly more effective than the other drugs tested, and did not suppress the RVR and AVE in a large number of dogs except when given in high doses by continuous infusion.
These ventricular escape rhythms are clearly unusual for at least two reasons: first, the escapes represent an early stage of digitalis intoxication, yet they resist suppression with large doses of agents that effectively suppress the spontaneous ventricular ectopy manifest with even greater degrees of digitalis excess.'7 Second, the RVR and AVE exhibit overdrive acceleration.'' This phenomenon of overdrive acceleration could be used to overcome drug-induced suppression of the RVR and AVE by pacing the heart at a faster basic cycle length.
It is possible that these unusual features may be manifestations caused by the slow current. In this regard, we have recently demonstrated that ventricular arrhythmias produced with barium and strontium, cations which are able to replace calcium in vitro as slow-current carrying ions,"8 also exhibit overdrive acceleration.'8 This observation plus the almost complete return of RVR and AVE to control values following calcium or isoproterenol administration provide indirect data suggesting a slow-channel pathogenesis. The reason for the ineffectiveness of verapamil in clinically-used doses (0.14 mg/kg), and the singular success of aprindine after only one-half to two-thirds the usual clinical dose (on a mg/kg basis) to suppress the RVR and AVE, particularly if these rhythms are due to the operation of the slow channel, is unknown. Some data indicate that aprindine also blocks the slow channel,14 while other studies suggest it is solely a fast-channel blocker.13 Perhaps aprindine is capable of blocking both the fast and slow channels, an action which may be required to suppress the RVR and AVE. Although this may be true, combinations of verapamil and lidocaine (to inhibit the rapid current) were ineffective in several trials in the present study.
It has been suggested that the sinus and A-V nodes are dependent on slow-channel mechanisms; these cells appear quite sensitive to the effects of verapamil and other slowchannel blockers.20 24 When verapamil was given by continuous intravenous infusion in the present study, the amount required to suppress the RVR and AVE was approximately ten times the amount necessary to slow spontaneous sinus node discharge rate or prolong A-V nodal conduction time and refractory period in the intact dog (Zipes, unpublished observations). Thus if the sinus and A-V nodes represent the "gold standard" against which to compare the response of a slow current to the blocking effects of verapamil, the RVR and AVE were an order of magnitude more resistant. Such comparisons are not entirely valid because, even if the sinus node and the ouabain-induced escapes are both dependent on slow current properties, fundamental differences exist between them.25 For example, the sinus node exhibits overdrive suppression20 while the RVR and AVE exhibit overdrive acceleration. Also, calcium administration reverses the suppressive effect of verapamil on the RVR and AVE, but does not reverse the suppressive defect of slow-channel blockers on the sinus and A-V nodes in the whole dog.22 It is possible that these digitalis-induced arrhythmias and sinus and A-V nodal cells are not both slow-current dependent; or perhaps more than one calciumdependent slow channel exists, with different electrophysiologic properties.
Further speculation as to the reason for the total success of aprindine would be premature until additional studies have been accomplished both in vivo and in vitro to elucidate better its electrophysiologic properties and mechanism of action. Preliminary data27 indicate that aprindine slows spontaneous sinus node automaticity and prolongs conduction time and refractory period in atrial and ventricular muscle, and in the A-V node. Depression of ventricular conduction may cause ventricular fibrillation in dogs with acute myocardial infarction at rapid pacing rates. 28 In the present study, following administration of the eighth dose of aprindine, transient marked QRS widening often was noted. Interventricular conduction time (IVCT), measured from the right to left ventricular epicardial recording electrodes during right ventricular pacing, was prolonged by 81% in 10 dogs immediately following aprindine (range 33-125%), and by 27% in 5 dogs (range 11-40%) thirty minutes following aprindine administration, although in each case the ventricular escapes were still significantly suppressed. However, successful suppression of RVR and AVE usually occurred between the fourth and sixth doses, which preceded the marked QRS prolongation.
Potassium chloride has long been known to be of value in treating arrhythmias due to digitalis intoxication. The mechanism responsible for the RVR and AVE (reentry or automaticity) cannot be deduced from the present study. The similarity of the ectopic activity with that noted in isolated Purkinje6' 7or atrial3' preparations suggests that automaticity may be the cause. It is likely that both the RVR and AVE are due to the same mechanism, differing only by effects produced by a shorter last cycle. Why RVR and AVE did not respond to all drugs in an exactly parallel fashion or why the RVR, which also had the effects of the shorter final cycle, was not more resistant is not entirely clear. Naturally, it is difficult to rule out re-entry following premature stimulation, and because of this, we elected to study also the AVE which would seem more likely to be caused by automatic discharge. Transient depolarizations, presumably due to automaticity, exhibit fixed coupling, and therefore the presence of fixed coupling, even following premature stimulation, does not a priori mean re-entry. 8 The relation, if any, of these observations to clinically occurring ventricular arrhythmias caused by digitalis is presently unknown. Perhaps these rhythms are ordinarily suppressed by the dominant sinus rhythm, unless a sudden slowing of the cardiac rhythm occurs. This study does suggest, however, that aprindine has a uniquely different antiarrhythmic action since it was the only antiarrhythmic agent tested that successfully suppressed the ouabaininduced AVE and RVR in clinically used doses. Aprindine holds potential promise as a new antiarrhythmic agent.3 To date, we have found it useful in several patients with ventricular tachycardia and ventricular fibrillation which were resistant to lidocaine, quinidine and procainamide. 33 In summary, we conclude that: 1) although the RVR and AVE represent an early stage of digitalis intoxication, they resist suppression with large doses of agents that effectively suppress the spontaneous ventricular ectopy manifest with even greater degrees of digitalis excess; 2) aprindine was the most successful agent in clinically-used doses capable of suppressing the RVR and AVE; 3) the ionic pathogenesis of the RVR and AVE is presently uncertain, although some data suggest the slow current may play a role; the return after suppression of the RVR and AVE with calcium infusion is consistent with a slow current concept, but the resistance to suppression with verapamil is not; 4) aprindine holds promise as a new antiarrhythmic agent.
